Bavarian Nordic A/S (OTCMKTS:BVNRY) Share Price Crosses Below Two Hundred Day Moving Average – Should You Sell?

Bavarian Nordic A/S (OTCMKTS:BVNRY)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.84 and traded as low as $9.36. Bavarian Nordic A/S shares last traded at $9.39, with a volume of 7,157 shares traded.

Bavarian Nordic A/S Stock Down 14.2 %

The firm has a market capitalization of $1.92 billion, a PE ratio of 21.55 and a beta of 1.71. The firm’s 50-day simple moving average is $10.85 and its 200-day simple moving average is $9.83.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last announced its quarterly earnings results on Thursday, August 22nd. The company reported $0.16 earnings per share (EPS) for the quarter. Bavarian Nordic A/S had a net margin of 11.50% and a return on equity of 12.50%. The business had revenue of $205.99 million for the quarter. On average, equities research analysts forecast that Bavarian Nordic A/S will post 0.57 earnings per share for the current year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.